ISPOR PATIENT REPORTED OUTCOMES (PRO) & PATIENT PREFERENCES SPECIAL INTEREST GROUP
Background on PRO:
The patients’ perspective has never been more important in medical evaluations and interventions. Clinical researchers are routinely incorporating Patient Reported Outcomes (PRO) assessments in trial programs and health care providers are increasingly considering PRO information to make decisions on treatment and patient management. In addition, regulators are asking for more meaningful endpoints that accurately reflect patient needs and values.
Background on Patient Preference Methods – Conjoint Analysis:
With regard to reimbursement recommendations and decisions, a growing number of Health Technology Assessment (HTA) agencies are calling for a greater role for patients and an increased understanding of the patient’s perspective. The FDA, Health Canada, and EMEA have called for evidence on patient preferences to inform benefit-risk assessments associated with pharmaceutical and device licensing and other regulatory decisions. Patient preference methods, such as conjoint analysis, are increasingly used in outcomes research to identify and value aspects of health and health care from the patient’s perspective.
